Appili Therapeutics Inc. (APLI)
TSX
Real-time Data
01:30 PM
Day's Range
0.015052 wk Range
0.01000Overview - APLI - Appili Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
14.88M
P/E (Forward)
‪-0.37‬
PEG Ratio
‪-0.37‬
Price / Sales (TTM)
‪8.13‬
EV / EBITDA
‪-2.28‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-11,434.43%‬
Return on Assets
‪-162.92%‬
Return on Equity
‪24.46%‬
Ownership
Shares Outstanding
132.36M
Float
117.93M
Held by Insiders
‪0.05%‬
Held by Institutions
‪10.84%‬
Price stats
Beta
‪-0.19‬
50-Day Avg
‪0.0132‬
200-Day Avg
‪0.0183‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - APLI - Appili Therapeutics Inc.
Peers - APLI - Appili Therapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on TSX.
- APLITSXAppili Therapeutics Inc.1.98MMarket Cap-33.33%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- APMTSXAndean Precious Metals Corp.1.08BMarket Cap+28.04%52-week change6.71P/E (Trailing)‪26.46%‬Profit Margin
- AIMTSXAimia Inc.241.29MMarket Cap-15.69%52-week change7.08P/E (Trailing)‪5.24%‬Profit Margin
- BCTTSXBriaCell Therapeutics Corp.48.37MMarket Cap-87.23%52-week change-0.13P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - APLI - Appili Therapeutics Inc.
About
Appili Therapeutics Inc. is a biopharmaceutical company focused on drug development aimed at addressing infectious diseases. This Canadian firm aims to combat some of the world's most challenging infections through innovative treatments and therapies. Appili Therapeutics operates in a critical sector of the healthcare…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
